Cellectis and UCL collaborate for off-the-shelf T cell fixes for leukemia
This article was originally published in Scrip
Executive Summary
The French genome engineering specialist, Cellectis has entered into a collaboration agreement with the University College London (UCL) covering the development of a T-cell adoptive immunotherapy for leukemia.